Plasmalogen Precursor Supplements as a Potential Treatment for Traumatic Brain Injury

Date Published April 20, 2026

Northeast Neuroscience, Neurology and Cognitive Disorders

Investigating plasmalogen precursor supplements as a potential treatment for traumatic brain injury.

Plasmalogen Precursor Supplements as a Potential Treatment for Traumatic Brain Injury is a Rowan-led research project awarded support through the New Jersey Health Foundation's 2024 grant cycle. This project explores the potential of plasmalogen precursor supplements to serve as a therapeutic approach for individuals who have experienced traumatic brain injury (TBI).

Learn more

COM Affiliation

Rowan-Virtua School of Osteopathic Medicine

Funding Type

State Government Award

Update This Listing

Help us provide the most up-to-date information about this project.

Questions?

For questions about these research projects please email us.